J&J Engaging With FDA, CDC Regarding Data on Vaccine Boosting

J&J will share new data shortly on boosting with its Covid-19 vaccine.

• Says data it shared in July showed that the durability of the immune response was strong, with no waning for at least eight months, the length of time that had been evaluated to date
• NOTE: Federal officials earlier Wednesday recommended booster shots of the Pfizer and Moderna vaccines

To view the source of this information, click here

To contact the reporter on this story:
Jim Silver in New York at jsilver@bloomberg.net

To contact the editor responsible for this story:
Maria Jose Valero at mvalero3@bloomberg.net

© 2021 Bloomberg L.P. …